Understanding the Global Ankylosing Spondylitis Market: Trends, Treatment, and Projections to 2032
Ankylosing Spondylitis Market: Trends, Treatment, and Projections
PORTLAND, OREGON, UNITED STATES, July 17, 2024 /EINPresswire.com/ -- π¬ππππππ π©πππππ π©πππππ: https://www.alliedmarketresearch.com/purchase-enquiry/A10281
Market Overview
β’ Market Size and Growth: The global ankylosing spondylitis market was valued at $5,140.94 million in 2020 and is expected to reach $8,110.59 million by 2030, with a CAGR of 4.6% from 2021 to 2030.
β’ Disease Overview: Ankylosing spondylitis is an inflammatory disease causing spinal vertebrae fusion, leading to reduced flexibility and potentially severe complications like breathing difficulties.
Symptoms and Diagnosis
β’ Early Signs: Includes morning stiffness, lower back and hip pain, neck pain, and fatigue.
β’ Diagnosis: Primarily through physical examination, supported by MRI and X-ray imaging.
Treatment and Management
β’ Current Approaches: Focus on symptom management as there is no known cure.
β’ Medications: NSAIDs, TNF inhibitors, corticosteroids, and DMARDs are commonly used.
β’ Emerging Therapies: Monoclonal antibodies like Taltz have shown efficacy in reducing inflammation and pain.
Market Drivers
β’ Prevalence: Increasing global prevalence, with significant screening results such as 7.3% positivity in Spain.
β’ Healthcare Infrastructure: Growth in orthopedic hospitals and diagnostic centers enhancing disease detection and treatment.
β’ Therapeutic Advancements: FDA approvals and advancements in therapy contribute to market expansion.
Market Segmentation
β’ By Drug Class: Dominated by NSAIDs; TNF inhibitors showing promising growth.
β’ By Distribution Channel: Major channels include hospital pharmacies, retail pharmacies, and online pharmacies.
Regional Insights
β’ North America: Largest market share due to high disease prevalence, robust healthcare infrastructure, and key player presence.
β’ Asia-Pacific: Expected highest growth rate (CAGR 6.1%) due to increasing healthcare facilities and population base.
Key Players
β’ Leading Companies: AbbVie, Amgen, Pfizer, Novartis, Lilly, among others, driving innovation and market growth.
Challenges
β’ Cost and Side Effects: High therapy costs and potential adverse drug effects pose challenges to market growth.
π¬ππππππ π©πππππ π©πππππ: https://www.alliedmarketresearch.com/purchase-enquiry/A10281
David Correa
Allied Market Research
email us here
+1 800-792-5285
Visit us on social media:
Facebook
X
